Decision ruleHaematology
Bone marrow involvement risk in Hodgkin lymphoma (Vassilakopoulos)
Clinical rule estimating the probability of bone marrow involvement to decide whether a marrow biopsy is needed.
Updated 30 October 2026
When to use it
Initial staging of Hodgkin lymphoma when PET-CT is unavailable or marrow involvement is uncertain.
What it needs
- B symptoms (fever, night sweats, weight loss > 10 %)
- Clinical stage III–IV before marrow biopsy
- Anaemia
- White cells < 6 × 10⁹/L
- Age ≥ 35 years
- Iliac or inguinal nodal involvement
The points for each answer and the automatic total are in the app.
How to interpret it
| Result | Interpretation |
|---|---|
| ≤ -1 | Low risk (≈ 0.3 %): biopsy may be omitted |
| 0–9 | Standard risk (≈ 4 %): unilateral biopsy |
| ≥ 10 | High risk (≈ 25 %): consider bilateral biopsy |
Practical tip
With staging PET-CT, marrow biopsy is no longer routine: PET detects focal involvement more sensitively.
2 more practical tips in the app.
Reference
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
